Cargando…

Administration of cardiac mesenchymal cells modulates innate immunity in the acute phase of myocardial infarction in mice

Although cardiac mesenchymal cell (CMC) therapy mitigates post-infarct cardiac dysfunction, the underlying mechanisms remain unidentified. It is acknowledged that donor cells are neither appreciably retained nor meaningfully contribute to tissue regeneration—suggesting a paracrine-mediated mechanism...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kang, Yi, Nasr, Marjan, Guo, Yiru, Uchida, Shizuka, Weirick, Tyler, Li, Hong, Kim, Jae, Moore, Joseph B., Muthusamy, Senthilkumar, Bolli, Roberto, Wysoczynski, Marcin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479609/ https://www.ncbi.nlm.nih.gov/pubmed/32901075 http://dx.doi.org/10.1038/s41598-020-71580-z

Ejemplares similares

Bone Marrow and Wharton’s Jelly Mesenchymal Stromal Cells are Ineffective for Myocardial Repair in an Immunodeficient Rat Model of Chronic Ischemic Cardiomyopathy
por: Tang, Xian-Liang, et al.
Publicado: (2023)

Immunomodulatory Effects of Cell Therapy after Myocardial Infarction
por: Moore, Joseph B, et al.
Publicado: (2021)

Macrophage Long Non-Coding RNAs in Pathogenesis of Cardiovascular Disease
por: Wysoczynski, Marcin, et al.
Publicado: (2020)

O-GlcNAcylation Negatively Regulates Cardiomyogenic Fate in Adult Mouse Cardiac Mesenchymal Stromal Cells
por: Zafir, Ayesha, et al.
Publicado: (2015)

Glucosamine regulates macrophage function in heart failure
por: Wysoczynski, Marcin, et al.
Publicado: (2022)

Long Non-coding RNAs in Endothelial Biology
por: Weirick, Tyler, et al.
Publicado: (2018)

Increasing workflow development speed and reproducibility with Vectools
por: Weirick, Tyler, et al.
Publicado: (2018)

Cardiac Mesenchymal Cells Cultured at Physiologic Oxygen Tension Have Superior Therapeutic Efficacy in Heart Failure Caused by Myocardial Infarction
por: Bolli, Robi A. R., et al.
Publicado: (2021)

Rigor Me This: What Are the Basic Criteria for a Rigorous, Transparent, and Reproducible Scientific Study?
por: Sansbury, Brian E., et al.
Publicado: (2022)

Repeated Administrations of Cardiac Progenitor Cells Are Superior to a Single Administration of an Equivalent Cumulative Dose
por: Tang, Xian‐Liang, et al.
Publicado: (2018)

The Effect of Cardiogenic Factors on Cardiac Mesenchymal Cell Anti-Fibrogenic Paracrine Signaling and Therapeutic Performance
por: Heidel, Justin S., et al.
Publicado: (2020)

Histone Deacetylase 1 Depletion Activates Human Cardiac Mesenchymal Stromal Cell Proangiogenic Paracrine Signaling Through a Mechanism Requiring Enhanced Basic Fibroblast Growth Factor Synthesis and Secretion
por: Moore, Joseph B., et al.
Publicado: (2017)

Investigation of RNA Editing Sites within Bound Regions of RNA-Binding Proteins
por: Weirick, Tyler, et al.
Publicado: (2019)

Do Changes in Innate Immunity Underlie the Cardiovascular Benefits of Exercise?
por: Chuong, Phillip, et al.
Publicado: (2019)

Single-dose of Synthetic MicroRNA-199a or MicroRNA-149 Mimic Does Not Improve Cardiac Function in a Murine Model of Myocardial Infarction
por: Nong, Yibing, et al.
Publicado: (2021)

A New Method to Stabilize C-Kit Expression in Reparative Cardiac Mesenchymal Cells
por: Wysoczynski, Marcin, et al.
Publicado: (2016)

Innate Lymphoid Cells and Myocardial Infarction
por: Yang, Wenling, et al.
Publicado: (2021)

ANGIOGENES: knowledge database for protein-coding and noncoding RNA genes in endothelial cells
por: Müller, Raphael, et al.
Publicado: (2016)

Collagen type XIX regulates cardiac extracellular matrix structure and ventricular function
por: Sadri, Ghazal, et al.
Publicado: (2022)

Identification of Heme Oxygenase 1 (HO-1) as a Novel Negative Regulator of Mobilization of Hematopoietic Stem/Progenitor Cells
por: Wysoczynski, Marcin, et al.
Publicado: (2014)

c-kit+ Cardiac Stem Cells Alleviate Post-Myocardial Infarction Left Ventricular Dysfunction Despite Poor Engraftment and Negligible Retention in the Recipient Heart
por: Hong, Kyung U., et al.
Publicado: (2014)

C-Kit Promotes Growth and Migration of Human Cardiac Progenitor Cells via the PI3K-AKT and MEK-ERK Pathways
por: Vajravelu, Bathri N., et al.
Publicado: (2015)

MicroRNAs, Innate Immunity and Ventricular Rupture in Human Myocardial Infarction
por: Zidar, Nina, et al.
Publicado: (2011)

Innate immune response after acute myocardial infarction and pharmacomodulatory action of tacrolimus in reducing infarct size and preserving myocardial integrity
por: Sheu, Jiunn-Jye, et al.
Publicado: (2013)

Repeated Intravenous Administration of Mesenchymal Stromal Cells Produces Cumulative Beneficial Effects in Chronic Ischemic Cardiomyopathy
por: Tang, Xian-Liang, et al.
Publicado: (2023)

Optimization of Timing and Times for Administration of Atorvastatin‐Pretreated Mesenchymal Stem Cells in a Preclinical Model of Acute Myocardial Infarction
por: Xu, Jun, et al.
Publicado: (2019)

Innate Lymphoid Cells Promote Recovery of Ventricular Function After Myocardial Infarction
por: Yu, Xian, et al.
Publicado: (2021)

Effects of Acute Potassium Chloride Administration on Ventricular Dysrhythmias after Myocardial Infarction in a Rat Model of Ischemia/Reperfusion
por: Madadi, Firoozeh, et al.
Publicado: (2022)

The prevalence of microvascular obstruction in acute myocardial infarction: importance of ST elevation, infarct size, transmurality and infarct age
por: Van Assche, Lowie MR, et al.
Publicado: (2011)

Long-term administration of recombinant canstatin prevents adverse cardiac remodeling after myocardial infarction
por: Sugiyama, Akira, et al.
Publicado: (2020)

Administration of Interleukin-15 Peptide Improves Cardiac Function in a Mouse Model of Myocardial Infarction
por: Ameri, Kurosh, et al.
Publicado: (2020)

Inflammation in myocardial infarction: roles of mesenchymal stem cells and their secretome
por: Shao, Lianbo, et al.
Publicado: (2022)

MicroRNA-21 prevents excessive inflammation and cardiac dysfunction after myocardial infarction through targeting KBTBD7
por: Yang, Linshan, et al.
Publicado: (2018)

Validity of Myocardial Infarction Diagnoses in Administrative Databases: A Systematic Review
por: McCormick, Natalie, et al.
Publicado: (2014)

Atorvastatin Therapy during the Peri-Infarct Period Attenuates Left Ventricular Dysfunction and Remodeling after Myocardial Infarction
por: Tang, Xian-Liang, et al.
Publicado: (2011)

Intracoronary Administration of Allogeneic Adipose Tissue–Derived Mesenchymal Stem Cells Improves Myocardial Perfusion But Not Left Ventricle Function, in a Translational Model of Acute Myocardial Infarction
por: Bobi, Joaquim, et al.
Publicado: (2017)

Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape
por: Krishnan, Anand, et al.
Publicado: (2022)

Assessment of Myocardial Diastolic Dysfunction as a Result of Myocardial Infarction and Extracellular Matrix Regulation Disorders in the Context of Mesenchymal Stem Cell Therapy
por: Piątek-Matuszak, Patrycja, et al.
Publicado: (2022)

Transplantation of expanded bone marrow-derived very small embryonic-like stem cells (VSEL-SCs) improves left ventricular function and remodelling after myocardial infarction
por: Zuba-Surma, Ewa K, et al.
Publicado: (2011)

Repair mechanisms of bone marrow mesenchymal stem cells in myocardial infarction
por: Wen, Zhuzhi, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_9s4su27akcaqpjoqe2qs4fjldt